Page last updated: 2024-10-29

iotrolan and Granuloma

iotrolan has been researched along with Granuloma in 1 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Granuloma: A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.

Research Excerpts

ExcerptRelevanceReference
"Iotrolan, which is a water-soluble and nonionic dimeric contrast medium, has potential greater safety for use in HSG than Lipiodol."1.29Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol. ( Azuma, H; Ishida, K; Iwai, K; Miyamoto, Y; Miyazawa, T; Tsujimoto, T; Uchimoto, R, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyamoto, Y1
Tsujimoto, T1
Iwai, K1
Ishida, K1
Uchimoto, R1
Miyazawa, T1
Azuma, H1

Other Studies

1 other study available for iotrolan and Granuloma

ArticleYear
Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
    Investigative radiology, 1995, Volume: 30, Issue:9

    Topics: Abdomen; Animals; Ascitic Fluid; Contrast Media; Feces; Female; Granuloma; Half-Life; Hysterosalping

1995